EUVIMEDEUVIMED entdecken
Crossref

Lipoprotein(a) is associated with ASCVD in individuals with non‐diabetes, prediabetes, or diabetes independent of CRP

Zenglei Zhang, Lin Zhao iD, Zeyu Wang, Xianliang Zhou, Xianlun Li, Weixian Yang, Xu Meng

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Zenglei Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical Co…. Hauptthemen laut MEDLINE: Prediabetic State, C-Reactive Protein, Lipoprotein(a), Atherosclerosis. Die Arbeit nennt 63 Literaturangaben. Gefördert von: the National High Level Hospital Clinical Research Funding, the Elite Medical Professionals Initiative of China-Japan Friendship Hospital, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Conflicting data have explored the association between lipoprotein(a) [Lp(a)] and atherosclerotic cardiovascular disease (ASCVD) among individuals with different glucose metabolism statuses. We aimed to prospectively evaluate this association and to assess whether it is modified by C‐reactive protein (CRP). Materials and Methods This population‐based cohort study was derived from the UK Biobank database. Lp(a) and CRP were measured between 2006 and 2010. Cox proportional hazards models and restricted cubic spline curves were employed to assess the relationship between Lp(a) levels and time to ASCVD events.

Results

A total of 307 269 participants without prevalent ASCVD were included, comprising 253 746 individuals with normal glucose regulation (NGR), 38 020 with prediabetes, and 15 503 with diabetes. The mean age was 57 years (Q1–Q3: 50–63), and 55.3% were female. Over a median follow‐up of 13.2 years, 29 521 ASCVD events occurred. Higher Lp(a) levels were associated with an increased risk of ASCVD across all glucose metabolism statuses. In fully adjusted models, the hazard ratio (95% confidence interval) for ASCVD comparing participants in the top 10% of Lp(a) with those in the bottom 33% was 1.28 (1.22–1.34) among those with NGR, 1.23 (1.12–1.35) among those with prediabetes, and 1.16 (1.02–1.31) among those with diabetes. No significant interactions were observed after stratification by CRP (0.05).

Conclusions

Elevated Lp(a) levels were associated with a higher risk of ASCVD across different glucose metabolism statuses, particularly among individuals with NGR and prediabetes, independent of baseline CRP levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prediabetic StateC-Reactive ProteinLipoprotein(a)AtherosclerosisHumansFemaleMiddle AgedMaleProspective StudiesRisk FactorsUnited KingdomBiomarkers

Stichwörter der Autor:innen

C‐reactive proteinatherosclerotic cardiovascular diseasediabeteslipoprotein(a)prediabetes

Substanzen

C-Reactive ProteinLipoprotein(a)Biomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing, China.

ORCID-Profile: Lin Zhao

Förderung

  • the National High Level Hospital Clinical Research Funding
  • the Elite Medical Professionals Initiative of China-Japan Friendship Hospital
  • the National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Science (CIFMS)

Zitieren

APA

Zhang, Z., Zhao, L., Wang, Z., Zhou, X., Li, X., Yang, W., & Meng, X. (2026). Lipoprotein(a) is associated with ASCVD in individuals with non‐diabetes, prediabetes, or diabetes independent of CRP. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70491

Vancouver

Zhang Z, Zhao L, Wang Z, Zhou X, Li X, Yang W, et al. Lipoprotein(a) is associated with ASCVD in individuals with non‐diabetes, prediabetes, or diabetes independent of CRP. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70491

BibTeX
@article{Zhang2026,
  author = {Zhang, Zenglei and Zhao, Lin and Wang, Zeyu and Zhou, Xianliang and Li, Xianlun and Yang, Weixian and Meng, Xu},
  title = {Lipoprotein(a) is associated with ASCVD in individuals with non‐diabetes, prediabetes, or diabetes independent of CRP},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70491}
}
Kostenlos starten →